Last updated: 30 July 2019 at 8:06pm EST

Kyle Lefkoff Net Worth




The estimated Net Worth of Kyle Lefkoff is at least 2.45 百万$ dollars as of 6 February 2019. Kyle Lefkoff owns over 35,000 units of Miragen Therapeutics Inc stock worth over 460,200$ and over the last 21 years Kyle sold MGEN stock worth over 1,989,730$.

Kyle Lefkoff MGEN stock SEC Form 4 insiders trading

Kyle has made over 19 trades of the Miragen Therapeutics Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently Kyle sold 35,000 units of MGEN stock worth 721,000$ on 6 February 2019.

The largest trade Kyle's ever made was exercising 70,000 units of Miragen Therapeutics Inc stock on 3 March 2015 worth over 196,000$. On average, Kyle trades about 12,675 units every 139 days since 2003. As of 6 February 2019 Kyle still owns at least 20,000 units of Miragen Therapeutics Inc stock.

You can see the complete history of Kyle Lefkoff stock trades at the bottom of the page.



What's Kyle Lefkoff's mailing address?

Kyle's mailing address filed with the SEC is C/O BOULDER VENTURES, 1941 PEARL STREET, SUITE 300, BOULDER, CO, 80302.

Insiders trading at Miragen Therapeutics Inc

Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over 636,110$ worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth 5,368,137$ . The most active insiders traders include Bennett S LebowBruce BoothPaul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of 2,345,685$. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth 2,268,935$.



What does Miragen Therapeutics Inc do?



Complete history of Kyle Lefkoff stock trades at Miragen Therapeutics Inc

インサイダー
取引
取引
合計金額
Kyle Lefkoff
ディレクター
販売 83,172$
9 Mar 2017
Kyle Lefkoff
ディレクター
販売 231,000$
6 Mar 2017
Kyle Lefkoff
ディレクター
販売 142,484$
24 Feb 2017
Kyle Lefkoff
ディレクター
販売 83,454$
22 Feb 2017


Miragen Therapeutics Inc executives and stock owners

Miragen Therapeutics Inc executives and other stock owners filed with the SEC include: